115 related articles for article (PubMed ID: 32489437)
1. Clinical trials for coronavirus disease 2019: What is being evaluated and what is not.
Arabi YM; Asseri A; Webb S; Marshall J; Al Moamary MS
Ann Thorac Med; 2020; 15(2):49-51. PubMed ID: 32489437
[TBL] [Abstract][Full Text] [Related]
2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
3. A scientificity and feasibility evaluation of COVID-19 clinical studies registered in China.
Tao L; Zhang H; Zhuo L; Liu Y; Qiao R; Zhao Y; Zhan S
Ann Transl Med; 2020 Jul; 8(13):817. PubMed ID: 32793662
[TBL] [Abstract][Full Text] [Related]
4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
5. An evidence mapping and analysis of registered COVID-19 clinical trials in China.
Lu L; Li F; Wen H; Ge S; Zeng J; Luo W; Wang L; Tang C; Xu N
BMC Med; 2020 Jun; 18(1):167. PubMed ID: 32493331
[TBL] [Abstract][Full Text] [Related]
6. Review of trials currently testing treatment and prevention of COVID-19.
Fragkou PC; Belhadi D; Peiffer-Smadja N; Moschopoulos CD; Lescure FX; Janocha H; Karofylakis E; Yazdanpanah Y; Mentré F; Skevaki C; Laouénan C; Tsiodras S;
Clin Microbiol Infect; 2020 Aug; 26(8):988-998. PubMed ID: 32454187
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19).
Zhu RF; Gao YL; Robert SH; Gao JP; Yang SG; Zhu CT
J Transl Med; 2020 Jul; 18(1):274. PubMed ID: 32631442
[TBL] [Abstract][Full Text] [Related]
8. Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials.
Nguyen VT; Rivière P; Ripoll P; Barnier J; Vuillemot R; Ferrand G; Cohen-Boulakia S; Ravaud P; Boutron I;
J Clin Epidemiol; 2021 Feb; 130():107-116. PubMed ID: 33096223
[TBL] [Abstract][Full Text] [Related]
9. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19).
Jiang F; Deng L; Zhang L; Cai Y; Cheung CW; Xia Z
J Gen Intern Med; 2020 May; 35(5):1545-1549. PubMed ID: 32133578
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and Nonpharmacological Studies on Coronavirus Disease 2019: A Mini-review of the Recent Evidence.
Bahmani AHA; Hoorang M; Hosseini S; Eskandari M; Shayestehfard K; Shekoohi M; Hatami-Mazinani N; Afifi S; Sabzghabaee AM; Peymani P
J Res Pharm Pract; 2020; 9(4):175-180. PubMed ID: 33912499
[TBL] [Abstract][Full Text] [Related]
11. The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans.
Checcucci E; Piramide F; Pecoraro A; Amparore D; Campi R; Fiori C; Elhage O; Kotecha P; Vyakarnam A; Serni S; Dasgupta P; Porpiglia F
Panminerva Med; 2022 Mar; 64(1):72-79. PubMed ID: 32456404
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov.
Huang J; He Y; Su Q; Yang J
Drug Des Devel Ther; 2020; 14():2159-2164. PubMed ID: 32581514
[TBL] [Abstract][Full Text] [Related]
13. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
15. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
Abd El-Aziz TM; Stockand JD
Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
[TBL] [Abstract][Full Text] [Related]
16. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
17. The Coronavirus Disease 2019 (COVID-19) Pandemic.
Baloch S; Baloch MA; Zheng T; Pei X
Tohoku J Exp Med; 2020 Apr; 250(4):271-278. PubMed ID: 32321874
[TBL] [Abstract][Full Text] [Related]
18. Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.
Jernigan DB;
MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(8):216-219. PubMed ID: 32106216
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): A systematic review.
Yang M; Shang YX; Tian ZY; Xiong M; Lu CL; Jiang Y; Zhang Y; Zhang YY; Jin XY; Jin QB; Zhang Y; Willcox ML; Liu JP
Integr Med Res; 2020 Sep; 9(3):100426. PubMed ID: 32483523
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
Varshney AS; Wang DE; Bhatt AS; Blood A; Sharkawi MA; Siddiqi HK; Vaduganathan M; Monteleone PP; Patel MR; Jones WS; Lopes RD; Mehra MR; Bhatt DL; Kochar A
Am Heart J; 2021 Feb; 232():105-115. PubMed ID: 33121978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
